The Online Investor
Drugs & Pharmaceuticals M&A image Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Tue., Feb. 7, 11:04 AM Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.

Slide #68. MWI Veterinary Supply, Inc. Assets of IVESCO Holdings LLC

Acquirer: MWI Veterinary Supply, Inc. (MWIV)
Acquiree: Assets of IVESCO Holdings LLC
Details: MWI Veterinary Supply, Inc. ("MWI" or "the Company") (NASDAQ: MWIV) announced today that it has completed its previously announced acquisition of substantially all of the assets of IVESCO Holdings LLC ("IVESCO") for an enterprise value of $67.5 million, plus a closing net working capital adjustment of $11.2 million. The total acquisition price represents a small premium over the net tangible assets acquired by MWI. This transaction is subject to a final post-closing working capital adjustment. The cash purchase price was funded with borrowings by the Company under its existing credit agreement.

MWI Veterinary Supply is a distributor of animal health products in the U.S. and in the U.K. Products that Co. sells include pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, specialty products, veterinary pet food, capital equipment and nutritional products. Co. markets these products to customers in both the companion animal and production animal markets. In addition, Co. provides its customers with a variety of services, including its e-commerce platform, technology management systems, pharmacy fulfillment, inventory management system, equipment procurement consultation, special order fulfillment, educational seminars and pet cremation.

Open the MWIV Page at The Online Investor »

Company Name: 
MWI Veterinary Supply Inc
Drugs & Pharmaceuticals

Open the MWIV Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree MWIV Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Drugs & Pharmaceuticals M&A - Slide 68 of 100 Page |

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.